Paper I
2025 March (Supplementary (SAY)) (2019 Scheme) · 100 marks · 180 min
Question
Assertion (A): Pralidoxime is most specific drug for organophosphate poisoning.
Reason (R): Organophosphates block AChE enzyme
Tap an option to answer
Qxix1 marksMCQs (A/R)
Answer
Correct answer: a) Both A and R are true, and R is the correct explanation of A
Both statements are true, and R correctly explains A: organophosphates irreversibly inhibit acetylcholinesterase; pralidoxime is the most specific antidote because it directly reactivates the poisoned enzyme itself (if given before the enzyme-organophosphate complex “ages”), reversing the actual cause of toxicity — unlike atropine, which only blocks the downstream muscarinic receptor effects symptomatically without touching the underlying enzyme inhibition.
Related Concepts
Other Years Asked
- 1((a)Neostigmine. ((b)Ondansetron.2024 March (Supplementary) (2019 Scheme)Short Essay · 8 marks
- 2((a)Outline the management of Organophospherous poisoning. ((b)Write the mechanism of action, therapeutic uses and adverse effects of Pancuronium.2023 July (Supplementary) (2019 Scheme)Short Essay · 8 marks
- 3A man aged 45 years presented with complaints of gradual onset double vision, drooping eyelids, difficulty in chewing food and weakness of limbs which is accentuated by exercise. The symptoms fluctuate in intensity over time. A provisional diagnosis of Myasthenia gravis is made.(a)Can a pharmacological test be performed to confirm the diagnosis. Explain(b)What are the medications used to treat Myasthenia gravis(c)Is there a surgical solution for this illness2025 March (Supplementary) (2010 Scheme)Essay · 6 marks
- 4Enumerate the topical group of agents used in the treatment of open angle glaucoma.Give examples and explain the mechanism of action of each group of drugs.(2+2+2)2019 February (2010 Scheme)Essay · 6 marks
- 5Read the clinical problem and answer the following questions:(a)After injection of succinylcholine i.v. to provide muscle relaxation, the patient developed(b)What is the probable reason for this.(c)Can edrophonium be given as antidote. If yes, why and if not why not.(d)What is the line of treatment.2017 August (Supplementary) (2010 Scheme)Essay · 6 marks
- 6A farmer was brought to the emergency department of the hospital presenting with lacrimation, salivation, sweating and breathlessness. O/E he is having miosis, blurring of vision, bronchospasm with copious trachea-bronchial secretions with BP- 100/60mmHg and PR-60/min. He gives history of spraying a strong insecticide in his agricultural field. ((a)What is the likely diagnosis ((b)Briefly outline the general measures of management ((c)Discuss in detail the drugs used to manage this condition with its rationale for use2023 March (Supplementary) (2010 Scheme)Essay · 6 marks
- 7A 22-year-old farmer was brought to the casualty with symptoms of nausea, vomiting, severe abdominal pain, lacrimation, salivation, blurring of vision, muscular twitches and weakness. He was suspected to have consumed Organo-phosphorous compound.(a)Outline the management of this poisoning(b)Discuss the mechanism of action and rationale for using the specific antidotes2024 March (Supplementary) (2010 Scheme)Essay · 6 marks
- 8Classify anticholinergic drugs. Describe the pharmacological actions, therapeutic uses and contraindications of atropine.(2+2+1+1)2021 February (Supplementary) (2010 Scheme)Essay · 6 marks
- 9Classify atropine substitutes, explain their uses and adverse effects(3+2+1)2022 May (Supplementary) (2010 Scheme)Essay · 6 marks
- 10A patient suffering from schizophrenia was being treated with haloperidol for the last four weeks. Now he developed rigidity, tremors, hypokinesia and classical gait. Answer the following:(a)What is the cause of these symptoms in this patient.(b)How will you treat this problem.(c)Why levodopa is combined with carbidopa in parkinsonism and mention its dose2017 February (2010 Scheme)Essay · 6 marks
- 11What is the rationale of using Beta-blockers in Glaucoma.2023 July (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 12Therapeutic uses and adverse effects of Neostigmine2022 February (2019 Scheme)Short Answer · 4 marks
- 13Pharmacotherapy of Organophosphorous poisoning2022 July (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 14Pharmacological basis for the use of Timolol in glaucoma.2024 June (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 15Pharmacological management of Myasthenia gravis.2022 July (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 16Treatment of organophosphorus poisoning2013 September (Supplementary) (2010 Scheme)Short Note · 3 marks
- 17Drug treatment of anti cholinesterase poisoning2013 April (2010 Scheme)Short Note · 3 marks
- 18Neostigmine2021 December (Supplementary) (2010 Scheme)Short Note · 3 marks
- 19Treatment of organophosphorous poisoning2014 September (Supplementary) (2010 Scheme)Short Note · 3 marks
- 20Atropine2015 February (2010 Scheme)Short Note · 3 marks
- 21Therapeutic uses and adverse effects of atropine.2016 October (Supplementary) (2010 Scheme)Short Note · 3 marks
- 22Neostigmine.2017 August (Supplementary) (2010 Scheme)Short Note · 3 marks
- 23Edrophonium2018 February (2010 Scheme)Short Note · 3 marks
- 24Pralidoxime in organophosphate compound poisoning2021 December (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 25Toxicities of atropine include the following:1.Bradycardia2.Dry mouth3.Miosis4.Psychotic behavior2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 26Assertion (A): Neostigmine and its congeners are the first line drugs used to restore muscle strength in myasthenia gravis.Reason (R): They improve muscle contraction by allowing acetylcholine released from prejunctional endings to accumulate and act on the nicotinic receptors over a wider area.2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 27The drug that should be used cautiously in Mrs. Rose, who has a history of bronchial asthma2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (Case) · 1 mark
- 28Explain briefly why physostigmine is preferred over neostigmine for the treatment of glaucoma.2015 February (2010 Scheme)Short Answer · 1 mark
- 29Anti- muscarinic drugs2017 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 30Drugs used in myasthenia gravis.2016 October (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 31Management of organophosphorus poisoning.2016 February (2010 Scheme)Short Answer · 1 mark
- 32Trihexyphenidyl in the treatment of Drug induced parkinsonism2024 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 33Explain the rationale for the use of oximes in organophosphorus poisoning.2017 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 34Rationale for use of pilocarpine in glaucoma2018 July (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 35Two uses and two adverse effects of atropine2014 March (2010 Scheme)Short Answer · 1 mark
- 36Rationale for use of physostigmine in atropine poisoning2015 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 37Rationale for the use of glycopyrrolate in pre-anesthetic medication.2016 October (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 38Cholinesterase reactivators2015 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 39Atropine as antisecretory agent2019 February (2010 Scheme)Short Answer · 1 mark
- 40The preferred first-line pharmacologic treatment for open-angle glaucoma is:2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (Case) · 1 mark
- 41Used in treatment of acute congestive glaucoma2018 February (2010 Scheme)Short Answer · 1 mark
- 42Why is benzhexol used in the treatment of drug induced Parkinsonism.2018 February (2010 Scheme)Short Answer · 1 mark
- 43Drugs used in Myasthenia gravis2013 April (2010 Scheme)Short Answer · 1 mark
- 44Trihexyphenidyl in drug induced extrapyramidal syndrome2021 May (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 45The Vasicoselective anticholinergic used in urinary frequency, urgency, and dysuria is2025 March (Supplementary (SAY)) (2019 Scheme)MCQ · 1 mark
- 46Bronchodilators (of two different groups)2013 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 47Vesico-selective anticholinergics2020 February (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 48Trihexyphenidyl /Levodopa in Drug induced parkinsonism.Name the following (Two examples for each): (5x1=5)2025 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 49Fluconazole / Ketoconazole in fungal meningitisName the following (Two examples for each) (5x1=5)2019 July (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 50Drugs for open angle glaucoma2019 July (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 51Physostigmine / Neostigmine in glaucoma managementName the following (Two examples for each): (5x1=5)2020 February (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 52Anticholinesterases2024 August (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 53Physostigmine/Neostigmine in atropine poisoning2022 May (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 54Physostigmine/Neostigmine for Atropine poisoning2022 October (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 55Atropine / Phenylephrine for refraction testing.2024 June (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 56Drugs used to treat Alzheimer’s disease.2024 June (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 57Edrophonium /Pyridostigmine for the diagnosis of Myasthenia gravis.2022 February (2019 Scheme)Short Answer · 0.2 marks
- 58Drugs used to treat Organophosphorus poisoning2022 February (2019 Scheme)Short Answer · 0.2 marks
- 59Vasicoselective anticholinergics.2023 January (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 60Levodopa/Benzhexol in chlorpromazine induced ParkinsonismName the following (Two examples for each): (8x1=8)2023 January (Supplementary) (2019 Scheme)Short Answer · 0.2 marks

